A carregar...
An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model
OBJECTIVE: Pulmonary fibrosis causes high morbidity and mortality in affected individuals. Recently, we showed that parenteral or intratracheal administration of a peptide derived from endostatin, called E4, prevents and ameliorates fibrosis using different models of dermal and pulmonary disease. No...
Na minha lista:
| Publicado no: | Int Immunopharmacol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482421/ https://ncbi.nlm.nih.gov/pubmed/26315492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2015.07.039 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|